CEOs Speak Out About Issues Affecting Their Abilit...

By Gail Garland In the summer of 2009, the CEOs of Ontario’s SME bioscience companies came together at the open invitation of Ontario Bioscience Industry Organization (OBIO) for a meeting hosted in Gowlings Toronto boardroom. On the agenda was a discussion of the future of Ontario’s bioscience industry and its unprecedented lack of access to capital, a worsening situation threatening the sustainability of the...

Discussion Notes: Quebec/Ontario Bioscience CEO Di...

What Quebec/Ontario Government funded programs are most effective? First and foremost, as entrepreneurs our duty is to create shareholder wealth with products and services the marketplace demands.  This cannot be substituted with or diverted by any government funding program. Quebec:  Tax holidays for key employees; tax exemption for new products developed in Quebec Quebec’s SR&ED tax credit regime is a...

New Fund Expands Options for Cash-strapped Biotech...

Ottawa (Dec. 16, 2009) – The new Tandem fund of $300 million announced last week presents a much-needed financing option for Canada’s biotechnology industry. The Fund received investments from the Business Development Bank of Canada (BDC), and Export Development Canada (EDC), contributing $80 and $75 million respectively to the Fund.”The fact that biotech firms are able to apply for funding from this new source...

Funding Opportunities in 2009-2010 for Bioscience ...

Funding Opportunities in 2009-2010 for Bioscience Companies:  What CEOs Need to Know About Ontario’s ETF and BIP Programs.  This OBIO event was held on Sept. 11, 2009 in Mississauga. The panel presentations are archived within the “Ministry of Research and Innovation” folder at:   http://hosting.epresence.tv/UTM/1/Page/Published/99.aspx Click on the “OBIO – OETF Launch Panel” event.  Password:...